SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-19-310897
Filing Date
2019-12-11
Accepted
2019-12-11 07:31:19
Documents
8

Document Format Files

Seq Description Document Type Size
1 SC TO-C d844499dsctoc.htm SC TO-C 15402
2 EX-99.1 d844499dex991.htm EX-99.1 9805
3 GRAPHIC g844499dsp003.jpg GRAPHIC 372088
4 GRAPHIC g844499dsp004.jpg GRAPHIC 500797
5 GRAPHIC g844499dsp005.jpg GRAPHIC 327356
6 GRAPHIC g844499dsp006.jpg GRAPHIC 274285
7 GRAPHIC g844499dsp007.jpg GRAPHIC 198572
8 GRAPHIC g844499dsp008.jpg GRAPHIC 246370
  Complete submission text file 0001193125-19-310897.txt   2671350
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11099 NORTH TORREY PINES ROAD SUITE 190 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD SUITE 190 LA JOLLA CA 92037 (858) 750-4700
Synthorx, Inc. (Subject) CIK: 0001609727 (see all company filings)

IRS No.: 464709185 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-90741 | Film No.: 191278962
SIC: 2834 Pharmaceutical Preparations